PREAMBLE: The Ministers of Health and representatives of African Union Member States gathered for the 2nd Vaccines and other Health Products Manufacturing Forum in Cairo, Arab Republic of Egypt from 4 ...

GNA-The Ghana Food and Drugs Authority (FDA) has spearheaded a joint initiative with National Regulatory Authorities (NRAs) ...

The memorandum included a demand for an immediate end to all military and financial support to the Rwandan government, which was sparked by Rwanda’s alleged backing of the M23 militia linked to ...

The snacks were reportedly only sold in Washington state and Oregon. Last Monday, the FDA classified the recall as Class 1, meaning they believe it’s “a situation in which there is a ...

ALSO READ: Rwanda FDA warns about illegal family planning medicines "The number of children should be proportional to the family's and the country's economic development so that we can have a ...

But in January, the FDA moved to revoke the approval of the synthetic dye in foodstuffs, giving manufacturers until January 2027 to phase it out. Drugmakers have until a year later, January 2028 ...

ROCHESTER, N.Y. (WROC) – On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare providers address pain management. Suzetrigine, ...

Vertex has set the therapy’s wholesale acquisition cost at $15.50 per 50mg pill. Credit: © 2025 Vertex Pharmaceuticals Incorporated. All Rights Reserved. The US ...

AFP reporters in North Kivu Jan 30, 2025 Jan 30, 2025 Updated Jan 31, 2025 The Rwanda-backed armed group M23 vowed on Thursday to march on the DR Congo capital, Kinshasa, as its fighters made ...

Congo’s security forces were fighting on Tuesday (January 28, 2025) against Rwanda-backed rebels who advanced into a key eastern city in a major escalation of a decades-long conflict.

Rwanda has accepted over 1,200 refugees fleeing the fighting, according to a government official on the border. People protest in Kinshasa, Democratic Republic of the Congo Tuesday, Jan. 28, 2025, ...

The new indications, approved Tuesday by the FDA, make Ozempic the most broadly indicated drug in its class, with the largest set of specific medical conditions that it may be prescribed to treat.